Disease Control and Prevention Vaccine Market

Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.

Disease Control and Prevention Vaccine Market contains market size and forecasts of Disease Control and Prevention Vaccine in global, including the following market information:

Global Disease Control and Prevention Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Disease Control and Prevention Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Disease Control and Prevention Vaccine companies in 2021 (%)

The global Disease Control and Prevention Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Live-Attenuated Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Disease Control and Prevention Vaccine include GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd and Daiichi Sankyo. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Disease Control and Prevention Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Disease Control and Prevention Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Disease Control and Prevention Vaccine Market Segment Percentages, by Type, 2021 (%)

• Live-Attenuated
• Inactivated
• Recombinant Sub Unit and Toxoid

Global Disease Control and Prevention Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Disease Control and Prevention Vaccine Market Segment Percentages, by Application, 2021 (%)

• Pediatric Vaccine
• Adult Vaccine

Global Disease Control and Prevention Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Disease Control and Prevention Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Disease Control and Prevention Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Disease Control and Prevention Vaccine revenues share in global market, 2021 (%)
• Key companies Disease Control and Prevention Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Disease Control and Prevention Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GSK
• Merck & Co., Inc
• Pfizer
• Sanofi
• AstraZeneca PLC
• Sinovac Biotech Ltd
• Astellas Pharma Inc
• Serum Institute of India Pvt. Ltd
• Daiichi Sankyo